Research ExplorerPublicationsExpression, epigenetic regulation, and humoral immunogenicit...

Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemia.

Standard

Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemia. / Luetkens, Tim; Schafhausen, Philippe; Uhlich, Frederike; Stasche, Tim; Akbulak, Ruken Özge; Bartels, Britta M; Hildebrandt, York; Gontarewicz, Artur; Kobold, Sebastian; Meyer, Sabrina; Gordic, Maja; Bartels, Katrin; Lajmi, Nesrine; Cao, Yanran; Kröger, Nicolaus; Bokemeyer, Carsten; Brümmendorf, Tim; Atanackovic, Djordje.

In: LEUKEMIA RES, Vol. 34, No. 12, 12, 2010, p. 1647-1655.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Luetkens, T, Schafhausen, P, Uhlich, F, Stasche, T, Akbulak, RÖ, Bartels, BM, Hildebrandt, Y, Gontarewicz, A, Kobold, S, Meyer, S, Gordic, M, Bartels, K, Lajmi, N, Cao, Y, Kröger, N, Bokemeyer, C, Brümmendorf, T & Atanackovic, D 2010, 'Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemia.', LEUKEMIA RES, vol. 34, no. 12, 12, pp. 1647-1655. <http://www.ncbi.nlm.nih.gov/pubmed/20409582?dopt=Citation>

APA

Luetkens, T., Schafhausen, P., Uhlich, F., Stasche, T., Akbulak, R. Ö., Bartels, B. M., Hildebrandt, Y., Gontarewicz, A., Kobold, S., Meyer, S., Gordic, M., Bartels, K., Lajmi, N., Cao, Y., Kröger, N., Bokemeyer, C., Brümmendorf, T., & Atanackovic, D. (2010). Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemia. LEUKEMIA RES, 34(12), 1647-1655. [12]. http://www.ncbi.nlm.nih.gov/pubmed/20409582?dopt=Citation

Vancouver

Luetkens T, Schafhausen P, Uhlich F, Stasche T, Akbulak RÖ, Bartels BM et al. Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemia. LEUKEMIA RES. 2010;34(12):1647-1655. 12.

Bibtex

@article{7d4390c5c6b244d98f1de59cc63b5373,
title = "Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemia.",
abstract = "Cancer-testis (CT) antigens represent attractive targets for tumor immunotherapy based on their tumor-restricted expression and immunogenicity. However, a broad picture of the expression of CT antigens and associated humoral immune responses in chronic myeloid leukemia (CML) is still missing.",
keywords = "Adult, Humans, Male, Aged, Female, Middle Aged, Disease-Free Survival, derivatives, Antigens, Neoplasm biosynthesis, Antimetabolites, Antineoplastic pharmacology, Azacitidine analogs, Drug Resistance, Neoplasm drug effects, Epigenesis, Genetic drug effects, Gene Expression Regulation, Leukemic drug effects, Immunity, Humoral drug effects, Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy, Neoplasm, Residual immunology, Piperazines therapeutic use, Pyrimidines therapeutic use, Adult, Humans, Male, Aged, Female, Middle Aged, Disease-Free Survival, derivatives, Antigens, Neoplasm biosynthesis, Antimetabolites, Antineoplastic pharmacology, Azacitidine analogs, Drug Resistance, Neoplasm drug effects, Epigenesis, Genetic drug effects, Gene Expression Regulation, Leukemic drug effects, Immunity, Humoral drug effects, Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy, Neoplasm, Residual immunology, Piperazines therapeutic use, Pyrimidines therapeutic use",
author = "Tim Luetkens and Philippe Schafhausen and Frederike Uhlich and Tim Stasche and Akbulak, {Ruken {\"O}zge} and Bartels, {Britta M} and York Hildebrandt and Artur Gontarewicz and Sebastian Kobold and Sabrina Meyer and Maja Gordic and Katrin Bartels and Nesrine Lajmi and Yanran Cao and Nicolaus Kr{\"o}ger and Carsten Bokemeyer and Tim Br{\"u}mmendorf and Djordje Atanackovic",
year = "2010",
language = "Deutsch",
volume = "34",
pages = "1647--1655",
journal = "LEUKEMIA RES",
issn = "0145-2126",
publisher = "Elsevier Limited",
number = "12",

}

RIS

TY - JOUR

T1 - Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemia.

AU - Luetkens, Tim

AU - Schafhausen, Philippe

AU - Uhlich, Frederike

AU - Stasche, Tim

AU - Akbulak, Ruken Özge

AU - Bartels, Britta M

AU - Hildebrandt, York

AU - Gontarewicz, Artur

AU - Kobold, Sebastian

AU - Meyer, Sabrina

AU - Gordic, Maja

AU - Bartels, Katrin

AU - Lajmi, Nesrine

AU - Cao, Yanran

AU - Kröger, Nicolaus

AU - Bokemeyer, Carsten

AU - Brümmendorf, Tim

AU - Atanackovic, Djordje

PY - 2010

Y1 - 2010

N2 - Cancer-testis (CT) antigens represent attractive targets for tumor immunotherapy based on their tumor-restricted expression and immunogenicity. However, a broad picture of the expression of CT antigens and associated humoral immune responses in chronic myeloid leukemia (CML) is still missing.

AB - Cancer-testis (CT) antigens represent attractive targets for tumor immunotherapy based on their tumor-restricted expression and immunogenicity. However, a broad picture of the expression of CT antigens and associated humoral immune responses in chronic myeloid leukemia (CML) is still missing.

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Disease-Free Survival

KW - derivatives

KW - Antigens, Neoplasm biosynthesis

KW - Antimetabolites, Antineoplastic pharmacology

KW - Azacitidine analogs

KW - Drug Resistance, Neoplasm drug effects

KW - Epigenesis, Genetic drug effects

KW - Gene Expression Regulation, Leukemic drug effects

KW - Immunity, Humoral drug effects

KW - Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy

KW - Neoplasm, Residual immunology

KW - Piperazines therapeutic use

KW - Pyrimidines therapeutic use

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Disease-Free Survival

KW - derivatives

KW - Antigens, Neoplasm biosynthesis

KW - Antimetabolites, Antineoplastic pharmacology

KW - Azacitidine analogs

KW - Drug Resistance, Neoplasm drug effects

KW - Epigenesis, Genetic drug effects

KW - Gene Expression Regulation, Leukemic drug effects

KW - Immunity, Humoral drug effects

KW - Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy

KW - Neoplasm, Residual immunology

KW - Piperazines therapeutic use

KW - Pyrimidines therapeutic use

M3 - SCORING: Zeitschriftenaufsatz

VL - 34

SP - 1647

EP - 1655

JO - LEUKEMIA RES

JF - LEUKEMIA RES

SN - 0145-2126

IS - 12

M1 - 12

ER -